Primary information |
---|
sequence ID | Seq_1505 |
Peptide sequence | DQVLSVLKGEE |
CancerPDF_ID | CancerPDF_ID395, CancerPDF_ID8773, |
PMID | 19795908,24694173 |
Protein Name | Apolipoprotein C-II,Apolipoprotein C-II |
UniprotKB Entry Name | APOC2_HUMAN,APOC2_HUMAN |
Fluid | Plasma,Ascites fluid |
M/Z | 608.82,NA |
Charge | 2,1 |
Mass (in Da) | NA,NA |
fdr | NA,NA |
Profiling Technique | LC-MS,LTQ-Orbitrap XL |
Peptide Identification technique | MALDI-TOF/TOF,X tandem for peptide identification |
Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
Labelled/Label Free | Labelled,Label Free |
FDR | less than 7%,NA |
CancerPDF_ID | CancerPDF_ID395, CancerPDF_ID8773, |
p-Value | NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,"X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
Length | 11,11 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Ovarian cancer |
Database | NCBI refseq Protein Database,IPI00021856 |
Modification | NA,NA |
Number of Patients | "41 normal, 24 patients",3 ovarian cancer patient and 3 non cancerous control |
Regulation | NA,Uniquely expressed in ovarian cancer patient |
Validation | NA,NA |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | NA |
IEDB | |